Overexposure of humans to heavy metals and essential metals poses a significant risk for the development of neurological and neurodevelopmental disorders. The mechanisms through which these metals exert their effects include the generation of reactive oxygen species, mitochondrial dysfunction, activation of inflammatory pathways, and disruption of cellular signaling. The function of glial cells in brain development and in the maintenance of homeostasis cannot be overlooked. The glial cells are particularly susceptible to metal-induced neurotoxicity. Accumulation of metals in the brain promotes microglial activation, triggering inflammatory responses that can coincide with other mechanisms of neurotoxicity, inducing alteration in synaptic transmission, cognitive deficit, and neuronal damage. In this review, we highlighted the role of glial dysfunction in some selected neurodegenerative diseases and neurodevelopmental disorders. We further dive into how exposure to metals such as nickel, manganese, methyl mercury, cadmium, iron, arsenic, and lead affect the functions of the microglia, astrocytes, and oligodendrocytes and the mechanisms through which they exert the effects on the brain in relation to some selected neurodegenerative diseases and neurodevelopmental disorders. Potential therapeutic interventions such as the use of new and improved chelating agents and antioxidant therapies might be a significant approach to alleviating these metal-induced glial perturbations.
The model organism Caenorhabditis elegans (C. elegans) is a microscopic roundworm discovered in 1900, which is widely becoming an acceptable animal model of human diseases in the scientific community, particularly in neurobiology and genetic research. C. elegans is considered of great interest to neuroscientists for studying basic biological processes and understanding neurodegenerative and neurodevelopmental disorders because of its small size, fully sequenced genome, simple and transparent body structure, and short life span. This chapter highlights the use of C. elegans in modeling diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS), alongside its contributions to neurodevelopmental and behavioral studies. Furthermore, advanced tools like CRISPR/Cas9 and RNA interference have augmented its utility, making it invaluable for therapeutic discovery and understanding gene-environment interactions. Challenges and future prospects are also presented hereon.